SYNLOGIC, INC. Temporary Equity, Dividends, Adjustment
SYNLOGIC, INC. (SYBX) reported Temporary Equity, Dividends, Adjustment of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2017-03-15
- SYNLOGIC, INC. temporary equity, dividends, adjustment for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for the quarter ending 2015-12-31 was $102.00K, a 85.67% decline year-over-year.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for the quarter ending 2015-09-30 was $1.55M, a 118.26% increase year-over-year.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for fiscal 2015 was $3.87M, a 37.08% increase from fiscal 2014.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for fiscal 2014 was $2.82M, a 89.15% increase from fiscal 2013.
- SYNLOGIC, INC. temporary equity, dividends, adjustment for fiscal 2013 was $1.49M.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 6 month | Temporary Equity, Dividends, Adjustment 9 month | Temporary Equity, Dividends, Adjustment 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | ||
| 2015-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $1.66M derived: sum of 2 quarters · filed 2017-03-15 | $3.20M derived: sum of 3 quarters · filed 2017-03-15 | $3.87M 10-K · filed 2017-03-15 |
| 2015-09-30 | $1.55M 10-Q · filed 2016-11-10 | $3.10M derived: sum of 2 quarters · filed 2016-11-10 | $3.77M 10-Q · filed 2016-11-10 | $4.51M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $1.54M 10-Q · filed 2016-08-15 | $2.21M 10-Q · filed 2016-08-15 | $2.95M derived: sum of 3 quarters · filed 2017-03-15 | $3.66M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $696.00K 10-Q · filed 2016-05-12 | $1.41M derived: sum of 2 quarters · filed 2017-03-15 | $2.12M derived: sum of 3 quarters · filed 2017-03-15 | |
| 2014-12-31 | $712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $1.42M derived: sum of 2 quarters · filed 2017-03-15 | $2.82M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $712.00K 10-Q · filed 2015-11-13 | $2.11M 10-Q · filed 2015-11-13 | ||
| 2013-12-31 | $1.49M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |